Michael Georgetson, MD

Care Provider Overall: 
5
Provider Reviews: 
74

Call for an appointment
866-GUTHRIE (866-488-4743)

  • Clinical Details
  • Education
  • News & Video
  • Clinical Trials
Hospital Privileges: 
  • Guthrie Corning Hospital
  • Guthrie Robert Packer Hospital
  • Guthrie Troy Community Hospital
Clinical Interests: 
  • Dysphagia
  • ERCP
  • Esophageal Diseases
  • Gastrointestinal Bleeding
  • Gastrointestional Neoplasia

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of Recommending Care Provider: 
5
Patients' Confidence in Care Provider: 
5
Time Care Provider Spent with Patient: 
5
Care Provider Spoke Using Clear Language: 
5
Care Provider Efforts to Include in Decisions: 
5
Care Provider's Concern for Questions and Worries: 
5
Care Provider's Explanations of Condition/Problem: 
5
Care Provider Information About Medications: 
5
Care Provider Instructions for Follow-Up Care: 
5
Care Provider's Friendliness and Courtesy: 
5
Residency: 
  • Robert Packer Hospital, Sayre, Pa.
Certification: 
  • American Board of IM/Gastroenterology
Education: 
  • Jefferson Medical College, Philadelphia, Pa.
Fellowship: 
  • Robert Packer Hospital, Sayre, Pa.
  • Fellow of the American College of Gastroenterology (FACG)
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson MD, FACG, Michael
Sponsor: Janssen
Details (Identifier #): NCT02407236
Title: CNTO1275UCO3001, A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson MD, FACG, Michael
Sponsor: AbbVie
Details (Identifier #): NCT02819635
Title: AbbVie M14-234, A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson MD, FACG, Michael
Sponsor: AbbVie
Details (Identifier #): NCT03006068
Title: M14-533, A Phase 3 Multicenter, Open-Label Extension (OLE) Study to Evaluate the Long-Term Safety and Efficacy of ABT-494 in Subjects with Ulcerative Colitis (UC)
Department: Gastroenterology
Diagnosis: Gastrointestinal - Miscellaneous
Principal Investigator: Georgetson MD, FACG, Michael
Sub-Investigator(s):
  • Friend CRNP, Kelly
Sponsor: Seres
Details (Identifier #): NCT03183128
Title: A Phase 3 Multicenter, RandomizeEd, Double Blind, Placebo COntrolled, Parallel Group Study to Evaluate the Safety, Tolerability, & Efficacy of SER-109 vs. Placebo to Reduce Recurrence of ClOstRidium Difficile Infection (CDI) in Adults (SERES-012)
Department: Gastroenterology
Diagnosis: Gastrointestinal - Miscellaneous
Principal Investigator: Georgetson MD, FACG, Michael
Sub-Investigator(s):
  • Friend CRNP, Kelly
Sponsor: Seres
Details (Identifier #): NCT03183141
Title: ECOSPOR IV: AN OPEN-LABEL EXTENSION OF STUDY SERES-012 EVALUATING SER-109 IN ADULT SUBJECTS WITH RECURRENT CLOSTRIDIUM DIFFICILE INFECTION (RCDI)

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Guthrie Patient: January 2018
Dr. was great.
Guthrie Patient: December 2017
Guthrie care provider *Dr. Georgetson is irreplaceable in my book. He is a five star provider along with *name removed*.
Guthrie Patient: November 2017
LOVE *Dr. Georgetson & did recommend him to a friend - who really liked him too!
Guthrie Patient: November 2017
I was told I would be called a week after my test. I was not called. I had pain in a specific spot in my back left kidney area after the test for 2 days and still have discomfort in my anus area which began after the test, not after the cleanse. I am now going to see my primary doctor as this has not cleared up. Neither of these pains were mentioned as possible side effects and not ones that I experienced when I had a colonoscopy the last time. I don't feel comfortable going back to this doctor due to these problems as I feel they have been caused by the exam/test and am concerned by the lack of follow-up by his office.
Guthrie Patient: October 2017
I chose Doctor Michael Georgetson, because I want him to give me an unbiased second opinion regarding my medical condition. I know that he is a very good doctor in the Gastroenterology medical field, because I was a patient of his 14 years ago. I am also expecting his efforts to include me in decisions about my treatment.
Guthrie Patient: September 2017
Friendly, spent time answering my questions.
Guthrie Patient: September 2017
really like this knowledgeable Dr. very caring about patients problems
Guthrie Patient: August 2017
I have been to GI dept. at Temple (Phila.) but feel care at Guthrie GI/Dr. *Georgetson is superior.
Guthrie Patient: August 2017
Dr. is great - have a lot of faith in him!
Guthrie Patient: July 2017
he could have at least addressed me by name when he did visit.be a little more personal with his approach with patients.